Kutane Lyme-Borreliose bei Kindern und Jugendlichen

Zusammenfassung

Die Lyme-Borreliose, übertragen durch die Zecke Ixodes ricinus und hervorgerufen durch die Spirochäte Borrelia burgdorferi, tritt in fast 90 % der Fälle mit Hauterscheinungen auf, dem Erythema migrans, manchmal auch multilokulär, dem Borrelien-Lymphozytom und der seltenen Acrodermatitis chronica atrophicans. Das typische Erythema migrans bedarf keiner Laborbestätigung, sondern wird sofort antibiotisch behandelt: bis 8 Jahre mit Amoxycillin, danach mit Doxycyclin. Die anderen Manifestationen bedürfen der serologischen Bestätigung. Die beste Prophylaxe ist die zügige Entfernung anheftender Zecken.

Summary

Manifestations of Lyme borreliosis, transmitted by the tick Ixodes ricinus and caused by the spirochete Borrelia burgdorferi, are cutaneous in nearly 90 % of cases as erythema migrans, sometimes multilocular, borrelial lymphocytoma and the rare acrodermatitis chronica atrophicans. Typical erythema migrans should not be confirmed by serology, but treated immediately: till 8 years of age with amoxicillin, at older ages with doxycycline. All other manifestations should be confirmed by serology. Best prophylaxis is by early removal of attached ticks.

Schlüsselwörter

Borrelia burgdorferi-Infektion - Erythema migrans - multiple Erythemata migrantia - Acrodermatitis chronica atrophicans

Keywords

Borrelia burgdorferi infection - Erythema migrans - multiple erythemata migrantia - acrodermatitis chronica atrophicans

• Literatur

• 1 Arnez M, Pleterski-Rigler D, Luznik-Bufon T. et al. Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin. Wien Klin Wochenschr 2002; 114: 498-504.
• 2 Arnez M. Antibiotic treatment of children with erythema migrans. Clin Infect Dis 2007; 44: 1133-1134.
• 3 Auwaerter PG, Bakken JS, Dattwyler RJ. et al. Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis 2011; 11: 713-719.
• 4 Andres C, Ziai M, Bruckbauer H. et al. Acrodermatitis chronica atrophicans in two children. Int J Dermatol 2010; 49: 180-183.
• 5 Belloni B, Andres C, Ring J. et al. Case report: 5-year-old with borrelial lymphocytoma. MMW Fortschr Med 2011; 153: 40.
• 6 Benedix F, Weide B, Broekaert S, Metzler G. et al. Early disseminated borreliosis with multiple erythema migrans and elevated liver enzymes: case report and literature review. Acta Derm Venereol 2007; 87: 418-421.
• 7 Bennet L, Danell S, Berglund J. Clinical outcome of erythema migrans after treatment with phenoxymethyl penicillin. Scand J Infect Dis 2003; 35: 129-131.
• 8 Berglund J. Natural history and long-term consequences of Lyme disease in children. Curr Opin Infect Dis 1999; 12: 265-269.
• 9 Berglund J, Eitrem R, Ornstein K. et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995; 333: 1319-1327.
• 10 Biner B, Oner N, Celtik C. et al. Ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound 2006; 34: 217-222.
• 11 Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 1998; 36: 2658-2665.
• 12 Brzonova I, Wollenberg A, Prinz JC. Acrodermatitis chronica atrophicans affecting all four limbs in an 11-year-old girl. Br J Dermatol 2002; 147: 375-378.
• 13 Christen HJ, Hanefeld F. Lyme-Borreliose im Kindesalter. Monatsschr Kinderheilkd 1993; 141: 513-526.
• 14 Dehnert M, Fingerle V, Klier C. et al. Seropositivity of Lyme Borreliosis and Associated Risk Factors: A Population-Based Study in Children and Adolescents in Germany (KiGGS). PLoS ONE 2012; 7: e41321 doi:
• 15 Eppes SC, Childs JA. Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics 2002; 109: 1173-1177.
• 16 Glatz M, Resinger A, Semmelweis K. et al. Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria. Acta Derm Venereol 2015; 95: 565-571.
• 17 Hofmann H. Lyme-Borreliose. Kutane Manifestationen. Hautarzt 2005; 56: 783-795.
• 18 Hofmann H. Variabilität der Kutanen Lyme-Borreliose Diagnostik und Therapie. Hautarzt 2012; 63: 381-389.
• 19 Huppertz HI, Karch H, Suschke HJ. et al. Lyme arthritis in European children and adolescents. Arthritis Rheum 1995; 38: 361-368.
• 20 Huppertz HI, Böhme M, Standaert SM. et al. Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis 1999; 18: 697-703.
• 21 Huppertz HI, Bartmann P, Heininger U. et al. Rational diagnostic strategies for Lyme borreliosis in children and adolescents: recommendations by the Committee for Infectious Diseases and Vaccinations of the German. Academy for Pediatrics and Adolescent Health Eur J Pediatr 2012; 1171: 1619-1624.
• 22 Nizic T, Velikanje E, Ružic- Sabljic E. et al. Solitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin. Wien Klin Wochenschr 2012; 124: 427-433.
• 23 Prinz JC, Kutasi Z, Weisenssel P. et al. „Borrelia-associated early-onset morphea“: A particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases. J Am Acad Dermatol 2009; 60: 248-255.
• 24 Regelin N, Montaruli E. Images in clinical medicine. Disseminated Lyme disease. N Engl J Med 2015; 372: 2136.
• 25 Robert Koch-Institut. Seroprävalenz der Lyme-borreliose bei Kindern und Jugendlichen in Deutschland. Epidemiol Bull 2012; 14: 113-120.
• 26 Salazar JC, Gerber MA, Goff CW. Long-term outcome of Lyme disease in children given early treatment. J Pediatr 1993; 122: 591-593.
• 27 Shapiro ED, Seltzer EG. Lyme disease in children. Semin Neurol 1997; 17: 39-44.
• 28 Wilske B. Lyme Borreliose, MIQ 12, Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. München: Urban und Fischer; 2000
• 29 Wilking H, Fingerle V, Klier C. et al Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008–2011. Emerg Infect Dis 2015; 21: 107-110.